Three Seattle Biotechs Named in BioSpace’s NextGen Bio “Class of 2021”

Three Washington biotech companies were named to BioSpace’s NextGen Bio “Class of 2021,” which ranks recently launched up-and-coming life sciences companies in North America based on five categories: finance, collaborations, pipeline, growth potential and innovation. The list represents the companies that have already made a tangible impact within the industry despite their short timespans of operation. Seattle-based Sana Biotechnology was listed at No. 1, with Shape Therapeutics and Sonoma Biotherapeutics coming in at No. 14 and No. 17, respectively.